Frankfurt - Delayed Quote EUR
Adaptimmune Therapeutics plc (473A.F)
0.2180
+0.0290
+(15.34%)
At close: April 25 at 3:49:30 PM GMT+2
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 4.77M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| BERTRAND WILLIAM C JR Chief Operating Officer | Sale at price 0.58 per share. | Direct | 3,243 | Jan 17, 2025 |
| RAWCLIFFE ADRIAN Chief Executive Officer | Sale at price 0.58 per share. | Direct | 17,773 | Jan 17, 2025 |
| LUNGER JOHN Officer | Sale at price 0.58 per share. | Direct | 3,243 | Jan 17, 2025 |
| NORRY ELLIOT Officer | Sale at price 0.58 per share. | Direct | 3,243 | Jan 17, 2025 |
| BERTRAND WILLIAM C JR Chief Operating Officer | Sale at price 0.57 - 0.59 per share. | Direct | 11,360 | Jan 15, 2025 |
| RAWCLIFFE ADRIAN Chief Executive Officer | Sale at price 0.57 - 0.59 per share. | Direct | 34,639 | Jan 15, 2025 |
| LUNGER JOHN Officer | Sale at price 0.57 - 0.59 per share. | Direct | 11,360 | Jan 15, 2025 |
| NORRY ELLIOT Officer | Sale at price 0.57 - 0.59 per share. | Direct | 12,920 | Jan 15, 2025 |
| PICCINA CINTIA Officer | Sale at price 0.57 per share. | Direct | 7,467 | Jan 15, 2025 |
| PICCINA CINTIA Officer | Sale at price 0.93 per share. | Direct | 22,814 | Jun 18, 2024 |
| BERTRAND WILLIAM C JR Chief Operating Officer | Sale at price 0.67 - 0.79 per share. | Direct | 16,423 | Jan 17, 2024 |
| RAWCLIFFE ADRIAN Chief Executive Officer | Sale at price 0.67 - 0.79 per share. | Direct | 27,594 | Jan 17, 2024 |
| LUNGER JOHN Officer | Sale at price 0.67 - 0.79 per share. | Direct | 15,889 | Jan 17, 2024 |
| NORRY ELLIOT Officer | Sale at price 0.67 - 0.79 per share. | Direct | 14,106 | Jan 17, 2024 |
| BERTRAND WILLIAM C JR Chief Operating Officer | Sale at price 0.84 - 0.85 per share. | Direct | 7,813 | Jan 12, 2024 |
| RAWCLIFFE ADRIAN Chief Executive Officer | Sale at price 0.84 - 0.85 per share. | Direct | 24,734 | Jan 12, 2024 |
| LUNGER JOHN Officer | Sale at price 0.84 - 0.85 per share. | Direct | 7,813 | Jan 12, 2024 |
| NORRY ELLIOT Officer | Sale at price 0.84 - 0.85 per share. | Direct | 10,015 | Jan 12, 2024 |
| RAWCLIFFE ADRIAN Chief Executive Officer | Sale at price 0.78 per share. | Direct | 1,874 | Sep 1, 2023 |
| LUNGER JOHN Officer | Sale at price 0.91 per share. | Direct | 2,804 | Aug 1, 2023 |
| MENZEL GARRY E Director | Sale at price 0.91 per share. | Direct | 43,447 | Jul 10, 2023 |
| RAWCLIFFE ADRIAN Chief Executive Officer | Sale at price 0.92 per share. | Direct | 2,146 | Jun 27, 2023 |
| MENZEL GARRY E Director | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Jun 1, 2023 |
| PICCINA CINTIA Officer | Sale at price 1.87 per share. | Direct | 22,230 | Jan 31, 2023 |
| BERTRAND WILLIAM C JR Chief Operating Officer | Sale at price 1.86 per share. | Direct | 8,250 | Jan 17, 2023 |
| RAWCLIFFE ADRIAN Chief Executive Officer | Sale at price 1.86 per share. | Direct | 18,686 | Jan 17, 2023 |
| LUNGER JOHN Officer | Sale at price 1.86 per share. | Direct | 8,250 | Jan 17, 2023 |
| NORRY ELLIOT Officer | Sale at price 1.86 per share. | Direct | 4,011 | Jan 17, 2023 |
| BERTRAND WILLIAM C JR Chief Operating Officer | Sale at price 1.71 - 1.75 per share. | Direct | 15,197 | Jan 12, 2023 |
| RAWCLIFFE ADRIAN Chief Executive Officer | Sale at price 1.71 - 1.75 per share. | Direct | 54,791 | Jan 12, 2023 |
| LUNGER JOHN Officer | Sale at price 1.71 - 1.75 per share. | Direct | 15,197 | Jan 12, 2023 |
| NORRY ELLIOT Officer | Sale at price 1.71 - 1.75 per share. | Direct | 19,421 | Jan 12, 2023 |
| BERTRAND WILLIAM C JR Chief Operating Officer | Sale at price 1.69 per share. | Direct | 6,071 | Jan 4, 2023 |
| RAWCLIFFE ADRIAN Chief Executive Officer | Sale at price 1.69 per share. | Direct | 8,594 | Jan 4, 2023 |
| LUNGER JOHN Officer | Sale at price 1.69 per share. | Direct | 1,863 | Jan 4, 2023 |
| NORRY ELLIOT Officer | Sale at price 1.69 per share. | Direct | 1,484 | Jan 4, 2023 |
| RAWCLIFFE ADRIAN Chief Executive Officer | Sale at price 1.97 per share. | Direct | 4,993 | Sep 1, 2022 |
| LUNGER JOHN Officer | Sale at price 1.77 per share. | Direct | 5,290 | Aug 1, 2022 |
| PICCINA CINTIA Officer | Sale at price 1.77 per share. | Direct | 37,314 | Aug 1, 2022 |
| LUNGER JOHN Officer | Sale at price 1.68 per share. | Direct | 3,311 | Jul 5, 2022 |
| RAWCLIFFE ADRIAN Chief Executive Officer | Sale at price 1.63 per share. | Direct | 4,176 | Jun 27, 2022 |
| WOOD GAVIN Chief Financial Officer | Purchase at price 1.64 per share. | Direct | 10,660 | May 20, 2022 |
| BERTRAND WILLIAM C JR Chief Operating Officer | Sale at price 3.19 per share. | Direct | 13,942 | Jan 18, 2022 |
| RAWCLIFFE ADRIAN Chief Executive Officer | Sale at price 3.19 per share. | Direct | 35,416 | Jan 18, 2022 |
| LUNGER JOHN Officer | Sale at price 3.19 per share. | Direct | 13,942 | Jan 18, 2022 |
| NORRY ELLIOT Officer | Sale at price 3.19 per share. | Direct | 6,770 | Jan 18, 2022 |
| BERTRAND WILLIAM C JR Chief Operating Officer | Sale at price 3.54 - 3.56 per share. | Direct | 21,376 | Jan 12, 2022 |
| RAWCLIFFE ADRIAN Chief Executive Officer | Sale at price 3.54 - 3.56 per share. | Direct | 61,877 | Jan 12, 2022 |
| LUNGER JOHN Officer | Sale at price 3.54 - 3.56 per share. | Direct | 17,222 | Jan 12, 2022 |
| NORRY ELLIOT Officer | Sale at price 3.54 - 3.56 per share. | Direct | 16,435 | Jan 12, 2022 |
Related Tickers
2105.HK Laekna, Inc.
13.660
-6.18%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
293.800
-4.67%
9969.HK InnoCare Pharma Limited
10.140
-3.61%
SION Sionna Therapeutics, Inc.
12.14
-3.65%
1672.HK ASCLETIS-B
6.280
-6.69%
ALXO ALX Oncology Holdings Inc.
0.5417
-9.87%
EWTX Edgewise Therapeutics, Inc.
14.84
-3.64%
9926.HK Akeso, Inc.
98.900
-1.10%
CYTK Cytokinetics, Incorporated
40.43
+0.25%
DYN Dyne Therapeutics, Inc.
11.06
-0.45%